Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples

Most patients with pancreatic ductal adenocarcinoma (PDAC) present with surgically unresectable cancer. As a result, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited s...

Full description

Saved in:
Bibliographic Details
Published in:Clinical cancer research Vol. 27; no. 4; p. 1082
Main Authors: Semaan, Alexander, Bernard, Vincent, Lee, Jaewon J, Wong, Justin W, Huang, Jonathan, Swartzlander, Daniel B, Stephens, Bret M, Monberg, Maria E, Weston, Brian R, Bhutani, Manoop S, Chang, Kyle, Scheet, Paul A, Maitra, Anirban, Jakubek, Yasminka A, Guerrero, Paola A
Format: Journal Article
Language:English
Published: United States 15.02.2021
Subjects:
ISSN:1557-3265, 1557-3265
Online Access:Get more information
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Most patients with pancreatic ductal adenocarcinoma (PDAC) present with surgically unresectable cancer. As a result, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited samples are often not considered adequate for genomic analysis, precluding the opportunity for enrollment on precision medicine trials. Applying an epithelial cell adhesion molecule (EpCAM)-enrichment strategy, we show the feasibility of using real-world EUS-FNA for in-depth, molecular-barcoded, whole-exome sequencing (WES) and somatic copy-number alteration (SCNA) analysis in 23 patients with PDAC. Potentially actionable mutations were identified in >20% of patients. Further, an increased mutational burden and higher aneuploidy in WES data were associated with an adverse prognosis. To identify predictive biomarkers for first-line chemotherapy, we developed an SCNA-based complexity score that was associated with response to platinum-based regimens in this cohort. Collectively, these results emphasize the feasibility of real-world cytology samples for in-depth genomic characterization of PDAC and show the prognostic potential of SCNA for PDAC diagnosis.
AbstractList Most patients with pancreatic ductal adenocarcinoma (PDAC) present with surgically unresectable cancer. As a result, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited samples are often not considered adequate for genomic analysis, precluding the opportunity for enrollment on precision medicine trials.PURPOSEMost patients with pancreatic ductal adenocarcinoma (PDAC) present with surgically unresectable cancer. As a result, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited samples are often not considered adequate for genomic analysis, precluding the opportunity for enrollment on precision medicine trials.Applying an epithelial cell adhesion molecule (EpCAM)-enrichment strategy, we show the feasibility of using real-world EUS-FNA for in-depth, molecular-barcoded, whole-exome sequencing (WES) and somatic copy-number alteration (SCNA) analysis in 23 patients with PDAC.EXPERIMENTAL DESIGNApplying an epithelial cell adhesion molecule (EpCAM)-enrichment strategy, we show the feasibility of using real-world EUS-FNA for in-depth, molecular-barcoded, whole-exome sequencing (WES) and somatic copy-number alteration (SCNA) analysis in 23 patients with PDAC.Potentially actionable mutations were identified in >20% of patients. Further, an increased mutational burden and higher aneuploidy in WES data were associated with an adverse prognosis. To identify predictive biomarkers for first-line chemotherapy, we developed an SCNA-based complexity score that was associated with response to platinum-based regimens in this cohort.RESULTSPotentially actionable mutations were identified in >20% of patients. Further, an increased mutational burden and higher aneuploidy in WES data were associated with an adverse prognosis. To identify predictive biomarkers for first-line chemotherapy, we developed an SCNA-based complexity score that was associated with response to platinum-based regimens in this cohort.Collectively, these results emphasize the feasibility of real-world cytology samples for in-depth genomic characterization of PDAC and show the prognostic potential of SCNA for PDAC diagnosis.CONCLUSIONSCollectively, these results emphasize the feasibility of real-world cytology samples for in-depth genomic characterization of PDAC and show the prognostic potential of SCNA for PDAC diagnosis.
Most patients with pancreatic ductal adenocarcinoma (PDAC) present with surgically unresectable cancer. As a result, endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) is the most common biospecimen source available for diagnosis in treatment-naïve patients. Unfortunately, these limited samples are often not considered adequate for genomic analysis, precluding the opportunity for enrollment on precision medicine trials. Applying an epithelial cell adhesion molecule (EpCAM)-enrichment strategy, we show the feasibility of using real-world EUS-FNA for in-depth, molecular-barcoded, whole-exome sequencing (WES) and somatic copy-number alteration (SCNA) analysis in 23 patients with PDAC. Potentially actionable mutations were identified in >20% of patients. Further, an increased mutational burden and higher aneuploidy in WES data were associated with an adverse prognosis. To identify predictive biomarkers for first-line chemotherapy, we developed an SCNA-based complexity score that was associated with response to platinum-based regimens in this cohort. Collectively, these results emphasize the feasibility of real-world cytology samples for in-depth genomic characterization of PDAC and show the prognostic potential of SCNA for PDAC diagnosis.
Author Lee, Jaewon J
Stephens, Bret M
Bernard, Vincent
Chang, Kyle
Semaan, Alexander
Weston, Brian R
Huang, Jonathan
Bhutani, Manoop S
Maitra, Anirban
Swartzlander, Daniel B
Wong, Justin W
Monberg, Maria E
Scheet, Paul A
Jakubek, Yasminka A
Guerrero, Paola A
Author_xml – sequence: 1
  givenname: Alexander
  orcidid: 0000-0001-5424-3217
  surname: Semaan
  fullname: Semaan, Alexander
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 2
  givenname: Vincent
  orcidid: 0000-0003-1555-608X
  surname: Bernard
  fullname: Bernard, Vincent
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 3
  givenname: Jaewon J
  orcidid: 0000-0002-5677-2398
  surname: Lee
  fullname: Lee, Jaewon J
  organization: Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 4
  givenname: Justin W
  orcidid: 0000-0002-6803-1060
  surname: Wong
  fullname: Wong, Justin W
  organization: Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 5
  givenname: Jonathan
  orcidid: 0000-0002-2867-3384
  surname: Huang
  fullname: Huang, Jonathan
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 6
  givenname: Daniel B
  surname: Swartzlander
  fullname: Swartzlander, Daniel B
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 7
  givenname: Bret M
  surname: Stephens
  fullname: Stephens, Bret M
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 8
  givenname: Maria E
  surname: Monberg
  fullname: Monberg, Maria E
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 9
  givenname: Brian R
  orcidid: 0000-0002-9872-1687
  surname: Weston
  fullname: Weston, Brian R
  organization: Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 10
  givenname: Manoop S
  orcidid: 0000-0002-1489-5947
  surname: Bhutani
  fullname: Bhutani, Manoop S
  organization: Department of Gastroenterology, Hepatology, and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 11
  givenname: Kyle
  surname: Chang
  fullname: Chang, Kyle
  organization: Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 12
  givenname: Paul A
  surname: Scheet
  fullname: Scheet, Paul A
  organization: Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 13
  givenname: Anirban
  surname: Maitra
  fullname: Maitra, Anirban
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
– sequence: 14
  givenname: Yasminka A
  orcidid: 0000-0003-1427-1015
  surname: Jakubek
  fullname: Jakubek, Yasminka A
  email: paguerrero@mdanderson.org, yjakubek@mdanderson.org
  organization: Department of Epidemiology, The University of Texas MD Anderson Cancer Center, Houston, Texas. paguerrero@mdanderson.org yjakubek@mdanderson.org
– sequence: 15
  givenname: Paola A
  surname: Guerrero
  fullname: Guerrero, Paola A
  email: paguerrero@mdanderson.org, yjakubek@mdanderson.org
  organization: Sheikh Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas
BackLink https://www.ncbi.nlm.nih.gov/pubmed/33188144$$D View this record in MEDLINE/PubMed
BookMark eNpNkE9Lw0AUxBdRtFU_grJHL9H9v-uxpLUKBUUtHsvL5kUjyW7MpoI3P7oRFYSB92B-M4eZkt0QAxJywtk559pdcGZdxpQU53l-nwmWCWPsDplwrW0mhdG7__4DMk3plTGuOFP75EBK7hxXakI-51jVoQ7PdHhBmse26_EFQ6rfkS4xxLb2dAWhTB46TDRW9A6C7xGG0Zhv_QANnZUj6KH39cgDXafvunuEJnuKfVPSRShj8rEbE7PU1f2YjYE-QNs1mI7IXgVNwuPfe0jWV4vH_Dpb3S5v8tkq88raISvAuKoolHNQGYfMSqe9riqvOb9Ey4ApV0oxSlpbOcOVAYla-0IJ4KIQh-Tsp7fr49sW07Bp6-SxaSBg3KaNUIZZI50TI3r6i26LFstN19ct9B-bv9XEF4pYcxg
CitedBy_id crossref_primary_10_1111_den_14344
crossref_primary_10_1002_1878_0261_13640
crossref_primary_10_1007_s12029_023_00922_7
crossref_primary_10_3390_cancers13174451
crossref_primary_10_3390_diagnostics11030469
crossref_primary_10_1038_s41467_022_31376_3
crossref_primary_10_3390_biomedicines11112874
crossref_primary_10_3390_jpm12122005
crossref_primary_10_1097_JS9_0000000000000200
crossref_primary_10_1016_j_csbj_2022_08_064
crossref_primary_10_3390_cancers16040794
crossref_primary_10_3390_cancers17040692
crossref_primary_10_3748_wjg_v29_i12_1863
crossref_primary_10_1186_s12943_023_01870_3
crossref_primary_10_1097_eus_0000000000000097
crossref_primary_10_1016_j_pan_2024_12_012
crossref_primary_10_1002_cncy_22589
crossref_primary_10_1007_s00535_023_02037_z
ContentType Journal Article
Copyright 2020 American Association for Cancer Research.
Copyright_xml – notice: 2020 American Association for Cancer Research.
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.1158/1078-0432.CCR-20-2667
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
Discipline Medicine
EISSN 1557-3265
ExternalDocumentID 33188144
Genre Research Support, Non-U.S. Gov't
Journal Article
Observational Study
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NCI NIH HHS
  grantid: T32 CA009599
– fundername: NCI NIH HHS
  grantid: P50 CA221707
– fundername: NCI NIH HHS
  grantid: U01 CA196403
– fundername: NCI NIH HHS
  grantid: U01 CA200468
– fundername: NCI NIH HHS
  grantid: U54 CA096297
– fundername: NCI NIH HHS
  grantid: U54 CA096300
– fundername: NCI NIH HHS
  grantid: T32 CA217789
GroupedDBID ---
18M
29B
2FS
2WC
34G
39C
53G
5GY
5RE
5VS
6J9
ABOCM
ACGFO
ACIWK
ACPRK
ACSVP
ADBBV
ADCOW
ADNWM
AENEX
AFHIN
AFOSN
AFRAH
AFUMD
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BR6
BTFSW
CGR
CS3
CUY
CVF
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
IH2
KQ8
L7B
LSO
NPM
OK1
P0W
P2P
QTD
RCR
RHF
RHI
RNS
SJN
TR2
W2D
W8F
WOQ
YKV
7X8
AAFWJ
AAJMC
ID FETCH-LOGICAL-c477t-ba68fbb488af68e07385c5ffc5119e70a048d32d32377f86146a3e55cb42a12b2
IEDL.DBID 7X8
ISICitedReferencesCount 23
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000620168400023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 1557-3265
IngestDate Thu Sep 04 16:16:14 EDT 2025
Wed Feb 19 02:27:50 EST 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 4
Language English
License 2020 American Association for Cancer Research.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c477t-ba68fbb488af68e07385c5ffc5119e70a048d32d32377f86146a3e55cb42a12b2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
ORCID 0000-0002-6803-1060
0000-0003-1555-608X
0000-0002-9872-1687
0000-0003-1427-1015
0000-0002-2867-3384
0000-0002-5677-2398
0000-0001-5424-3217
0000-0002-1489-5947
OpenAccessLink https://aacrjournals.org/clincancerres/article-pdf/27/4/1082/2068994/1082.pdf
PMID 33188144
PQID 2460763882
PQPubID 23479
ParticipantIDs proquest_miscellaneous_2460763882
pubmed_primary_33188144
PublicationCentury 2000
PublicationDate 2021-02-15
PublicationDateYYYYMMDD 2021-02-15
PublicationDate_xml – month: 02
  year: 2021
  text: 2021-02-15
  day: 15
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Clinical cancer research
PublicationTitleAlternate Clin Cancer Res
PublicationYear 2021
SSID ssj0014104
Score 2.469983
Snippet Most patients with pancreatic ductal adenocarcinoma (PDAC) present with surgically unresectable cancer. As a result, endoscopic ultrasound-guided fine-needle...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 1082
SubjectTerms Aged
Aged, 80 and over
Carcinoma, Pancreatic Ductal - genetics
Carcinoma, Pancreatic Ductal - mortality
Carcinoma, Pancreatic Ductal - pathology
Carcinoma, Pancreatic Ductal - therapy
DNA Copy Number Variations
DNA Mutational Analysis - methods
Endoscopic Ultrasound-Guided Fine Needle Aspiration
Feasibility Studies
Female
Genetic Heterogeneity
Genomics
Humans
Male
Middle Aged
Mutation
Pancreas - diagnostic imaging
Pancreas - pathology
Pancreatic Neoplasms - genetics
Pancreatic Neoplasms - mortality
Pancreatic Neoplasms - pathology
Pancreatic Neoplasms - therapy
Pilot Projects
Prognosis
Progression-Free Survival
Whole Exome Sequencing
Title Defining the Comprehensive Genomic Landscapes of Pancreatic Ductal Adenocarcinoma Using Real-World Endoscopic Aspiration Samples
URI https://www.ncbi.nlm.nih.gov/pubmed/33188144
https://www.proquest.com/docview/2460763882
Volume 27
WOSCitedRecordID wos000620168400023&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1JS8QwFA5uiBf3ZdyI4DXaSdKmPckw43LQYRgV5jYkaYIebHU6evan-17aYU6CIJTeEkr68r0vectHyHmU8dgJq1jbWMmktp5p7xTLnDPGooC0yoPYhOr309EoGzQXblWTVjnDxADUeWnxjvySywSO3AII4dX7B0PVKIyuNhIai2RZAJXBlC41mkcRZDvIB4LLhI3Ek7ip4GnHKYAFdpaVgl90u0MwFQaOSv3OMoO3udn473dukvWGZ9JObRhbZMEV22T1oYmk75DvnvNBG4ICA6SIChP3Uiez01sXapXpPZYBY4JURUtPB2AfgWFa2vu0U5wcMAtc4QRmLN80DdkHdAjMk4UUHXpd5CVWvcCITh3QByOgjxobEle75Pnm-ql7xxo1BmalUlNmdJJ6Y2DDa5-kLsI2ODb23mIk0qlIAxbkgsMjlPIpuP1ECxfH1kiu29zwPbJUlIU7IDRLZGQASqRNcsltnkVCp2AmMk498DXXImeztR2DtWMIQxeu_KzG89Vtkf36B43f67YcYwHwlML58PAPo4_IGsfkFFR2iY_Jsoe97k7Iiv2avlaT02BG8O4PHn4Akx3S0w
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Defining+the+Comprehensive+Genomic+Landscapes+of+Pancreatic+Ductal+Adenocarcinoma+Using+Real-World+Endoscopic+Aspiration+Samples&rft.jtitle=Clinical+cancer+research&rft.au=Semaan%2C+Alexander&rft.au=Bernard%2C+Vincent&rft.au=Lee%2C+Jaewon+J&rft.au=Wong%2C+Justin+W&rft.date=2021-02-15&rft.eissn=1557-3265&rft.volume=27&rft.issue=4&rft.spage=1082&rft_id=info:doi/10.1158%2F1078-0432.CCR-20-2667&rft_id=info%3Apmid%2F33188144&rft_id=info%3Apmid%2F33188144&rft.externalDocID=33188144
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1557-3265&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1557-3265&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1557-3265&client=summon